Novartis’s Beovu Launch Clouded By Safety Worries

Beovu Uncertainty Should Benefit Regeneron’s Eylea

 
• By Sten Stovall
  
Macular degeneration
Beovu safety worries raised by American Society of Retinal Specialists
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Sensory

More from Therapeutic Category